Liveblog Archief woensdag 15 juli 2020

Washington (CNN) - Hospital data on coronavirus patients will now be rerouted to the Trump administration instead of first being sent to the US Centers for Disease Control and Prevention, the Department of Health and Human Services confirmed to CNN on Tuesday.

The move could make data less transparent to the public at a time when the administration is downplaying the spread of the pandemic, and threatens to undermine public confidence that medical data is being presented free of political interference.

TOP NEWS
• Blow for EU as Apple wins fight against $15 billion tax order
Apple scored a major win as Europe's second-highest court rejected an EU order for the iPhone maker to pay 13 billion euros ($15 billion) in Irish back taxes, dealing a blow to the bloc's attempts to crack down on sweetheart tax deals.​
• Google buys 7.7% of Reliance's digital unit for $4.5 billion
India's Reliance Industries said Alphabet's Google will buy a 7.7% stake in its digital unit for $4.5 billion, winning the backing of another U.S. tech giant after Facebook in late April.
• UnitedHealth profit doubles as COVID-19 delays some surgeries
UnitedHealth Group said its second-quarter profit more than doubled, as the largest U.S. health insurer's medical costs fell after the coronavirus outbreak forced Americans to delay less urgent surgeries and procedures.
• Trump on UK's Huawei ban: 'I did this myself'
U.S. President Donald Trump said that he was responsible for Prime Minister Boris Johnson's decision to ban Huawei from Britain's 5G network from the end of 2027, a remark China said proved London's move was about politics rather than security.
• U.S. Paycheck Protection hit some of its mark, but missed the most vulnerable
The Paycheck Protection Program appears to have thrown a critical safety net under U.S. middle and upper-middle-wage jobs, but it faltered when it comes to lower-paying positions and the industries hit hardest by the coronavirus pandemic, according to a Reuters analysis of loan details.​


BEFORE THE BELL
Wall Street futures rose along with world shares following reports of progress in developing a COVID-19 vaccine, offsetting rising tensions between the United States and China. Risk sentiment pushed the dollar down. Gold prices were lower but held above the $1,800 level. Oil gained following a sharp drop in U.S. crude inventories, with the market waiting for OPEC and its allies to decide on the easing of output curbs later in the day as the global economy slowly recovers from the COVID-19 pandemic. U.S. industrial production and import prices data for June is scheduled for release later in the day. ​


STOCKS TO WATCH
Results
• UnitedHealth Group Inc (UNH). The health insurer said its second-quarter profit more than doubled, as the company's medical costs fell after the coronavirus outbreak forced Americans to delay less urgent surgeries and procedures. The company maintained its full-year adjusted profit forecast of $16.25 to $16.55 per share, saying demand for healthcare began to recover in May and approached more typical levels by the end of the second quarter. For the quarter, the company's medical loss ratio touched historic lows of 70.2%, compared with 83.1% a year earlier. Net earnings attributable to shareholders jumped to $6.64 billion, or $6.91 per share, in the three months ended June 30, from $3.29 billion, or $3.42 per share, a year earlier. Total revenue rose to $62.14 billion from $60.60 billion.​
• Infosys Ltd (INFY). The company reported a stronger-than-expected quarterly profit, as the software services firm managed to secure large client deals during the COVID-19 pandemic. Infosys' net profit climbed to 42.33 billion rupees in the June quarter, from 37.98 billion rupees a year earlier. Analysts on average had expected a profit of 39.87 billion rupees, according to Refinitiv data. Revenue rose 8.5% to 236.65 billion rupees.

Deals Of The Day
• Alphabet Inc (GOOGL). India's Reliance Industries said Google will buy a 7.7% stake in its digital unit for $4.5 billion, winning the backing of another U.S. tech giant after Facebook in late April. Google's investment in Jio Platforms is at a valuation of $58.01 billion for the digital platform, the company said in a statement. Strategic and financial investors have committed a total of $20.22 billion in the last few months, Reliance chairman Mukesh Ambani said at the company's annual shareholders meeting hosted via a webcast. The deal with Google will bolster Reliance's lofty tech ambitions, such as building smart homes, using solutions similar to Amazon's Alexa voice assistant, connected cars and security systems.

IPOs
• GoHealth Inc (GOCO). The company said on Tuesday it raised $913.5 million in its initial public offering, pricing its shares above the indicated price range amid rapid growth in its U.S. online health insurance marketplace. The IPO, which priced 43.5 million shares at $21 each, more than quadrupled the valuation of the online health insurance broker in less than a year. The indicated price range was $18 to $20. The IPO gives GoHealth a valuation of close to $6.6 billion.

In Other News
• Apple Inc (AAPL). Apple scored a major win as Europe's second-highest court rejected an EU order for the iPhone maker to pay $15 billion in Irish back taxes, dealing a blow to the bloc's attempts to crack down on sweetheart tax deals. "The General Court annuls the contested decision because the Commission did not succeed in showing to the requisite legal standard that there was an advantage for the purposes of Article 107(1) TFEU1," judges said, referring to EU competition rules. Separately, data from SensorTower showed more than 2,500 mobile games were removed from Apple's China app store in the first week of July, four times as many in the same period in June, after Apple closed a loophole to comply with Chinese licence requirements.​
• AstraZeneca PLC (AZN). Positive news on initial trials of the University of Oxford's potential COVID-19 vaccine that has been licensed to AstraZeneca could be announced as soon as Thursday, ITV's political editor Robert Peston said, citing a source. The project has started Phase III of the human trials to assess how the vaccine works in a large number of people over the age of 18, but has yet to report Phase I trial results. "I am hearing there will be positive news soon (perhaps tomorrow) on initial trials of the Oxford Covid-19 vaccine that is backed by AstraZeneca," Peston said in a blog post.​
• Atlas Air Worldwide Holdings Inc (AAWW). The U.S. National Transportation Safety Board (NTSB) cited cockpit mistakes by the first officer and pilot in a February 2019 fatal crash of an Atlas Air cargo plane. The NTSB cited the first officer’s inappropriate response to an inadvertent activation of the airplane’s go-around mode at 6,000 feet that resulted in his spatial disorientation and led him to place the airplane in a steep dive from which it did not recover. Board members said the crash could have been prevented if the Federal Aviation Administration (FAA) had finalized a pilot records database.
• BHP Group Ltd (BHP). More than 200,000 Brazilian people and groups will next week kick off a $6.3 billion lawsuit against the Anglo-Australian miner in Britain over a 2015 dam failure that led to Brazil's worst environmental disaster. An initial, eight-day hearing will establish whether the case can be heard in Britain, although the judge is expected to reserve judgment until later in the year. If successful, further trials are expected to determine liability and quantify damages.
• CoreLogic Inc (CLGX). The property data and analytics company on Tuesday again rejected an unsolicited $7 billion buyout offer as inadequate after meeting with the two investment firms that made the bid, Senator Investment Group LP and Cannae Holdings Inc. "Despite the company's recent guidance update for 2020 and disclosure of financial projections for 2021 and 2022, Senator and Cannae have not revised their proposal to deliver appropriate value to our shareholders," CoreLogic said in a statement issued after the telephone meeting on Tuesday. During the meeting, the investor group asked CoreLogic for more financial documents to better assess the profitability of its business segments, people familiar with the matter said.
• Delta Air Lines Inc (DAL). The airlines said it would record charges of up to $3 billion on employee voluntary retirement and separation plans in the current quarter, as the U.S. carrier looks to cut costs due to the coronavirus crisis. Delta, like other large U.S. airlines, has been encouraging workers to leave voluntarily before a government ban on forced job cuts expires on Sept. 30. The company, which had more than 91,000 employees in 2019, said on Tuesday that about 17,000 of them opted for buyouts.​
• Diamondback Energy Inc (FANG). The shale producer on Tuesday cut its 2020 production forecast due to higher-than-expected curtailed volumes in the second quarter and volatile oil prices. Diamondback said it had suspended almost all completion activity and cut about 5% of production in the second quarter, adding that nearly all of the curtailed production was now back online. The company said it brought back two completion crews to work in June and a third crew in July.
• Energy Transfer LP (ET). The Dakota Access oil pipeline can continue to operate amid an ongoing court battle, a U.S. Appeals Court said on Tuesday, setting aside for now a lower court's order earlier this month to shut and empty the line. The U.S. Court of Appeals for the District of Columbia granted Dakota Access, controlled by Energy Transfer, an administrative stay while it considers whether the line, long opposed by local tribes and environmental activists, should be shut due to permitting issues dating to 2017. Tuesday's ruling means oil can keep flowing through the 570,000-barrel-per-day pipeline, which runs from North Dakota's oil production fields to Midwest and Gulf Coast refineries.
• GlaxoSmithKline PLC (GSK). An independent panel to the U.S. Food and Drug Administration on Tuesday voted in favor of approving GlaxoSmithKline's experimental treatment for a common form of blood cancer, saying the benefits of the treatment outweigh the risks. The FDA will now make a final decision on the treatment. While the agency is not bound to follow the recommendation of its advisory panel, it usually does. GSK had said it was confident in the benefit/risk profile of the drug, and proposed that it should be managed through modifying or interrupting the course of treatment.
• Green Plains Inc (GPRE) & Archer Daniels Midland Co (ADM). Green Plains sued Archer Daniels Midland on Tuesday, accusing the global grain trader of manipulating the price of the biofuel to profit from its positions in the derivatives market. Green Plains filed the proposed class action with the U.S. District Court of Nebraska, where it also claimed that senior ADM officials knew of the alleged manipulation. According to the complaint, ADM was aggressively selling ethanol on the cash market at the Argo terminal just outside of Chicago - and timing such selling 30 minutes ahead of the close of the trading day.
• Merck & Co Inc (MRK). COVID-19 vaccines under development are not guaranteed to work and people who say to expect a vaccine before year-end are doing a "grave disservice to the public," Merck's chief said, according to a Harvard Business Review report. The potential vaccines may not have the qualities needed to be rapidly deployed in large numbers of people, Chief Executive Kenneth Frazier said in an interview published on Monday. "If you're going to use a vaccine on billions of people, you better know what that vaccine does."
• Moderna Inc (MRNA). The company's experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, U.S. researchers reported on Tuesday. Volunteers who got two doses of the vaccine had high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from COVID-19, the team reported in the New England Journal of Medicine. No study volunteers experienced a serious side effect, but more than half reported mild or moderate reactions such as fatigue, headache, chills, muscle aches or pain at the injection site. These were more likely to occur after the second dose and in people who got the highest dose.
• New York Times Co (NYT). The media company will shift part of its Hong Kong office to Seoul, the latest sign of the chill spreading in the global financial centre just two weeks after Beijing imposed a new national security law. "Given the uncertainty of the moment, we are making plans to geographically diversify our editing staff," a spokeswoman for the Times told Reuters. "We will maintain a large presence in Hong Kong and have every intention of maintaining our coverage of Hong Kong and China."
• Tesla Inc (TSLA). A central Texas county that includes Austin on Tuesday approved a plan to provide millions in tax subsidies to the carmaker if it builds a $1.1 billion vehicle factory in the area. A majority of commissioners in Travis County voted in favor of providing the electric carmaker with a tax rebate worth at least $14.7 million. That brings the total amount of tax rebates to nearly $65 million after the Del Valle school district, which includes the proposed factory site, approved a $50 million incentive on Thursday.
• Walt Disney Co (DIS). Disneyland Paris welcomed back visitors after a four-month closure due to the coronavirus outbreak, with face masks and social distancing the order of the day. A steady stream of visitors trickled in during the morning, with one group wearing Mickey Mouse ears and dancing with glee as they entered Europe's most visited theme park. Masks were mandatory and advance booking required. Visitors to the park, which has imposed a limited capacity, were told to keep a metre away from others, and hundreds of sanitising-gel and hand-washing stations were scattered around.


FOCUS
'Hands free': Automakers race to next level of not quite self-driving cars
Autopilot, ProPilot, CoPilot: Automakers have many names for new systems that allow for hands-free driving, but no safety or performance standards to follow as they roll out the most significant changes to vehicle technology in a generation. Spurred by Tesla Inc's success and eager to start profiting from billions spent on autonomous driving research, automakers are accelerating plans to automate routine driving tasks such as cruising on a highway and make them widely available within five years, industry executives said.


ANALYSTS' RECOMMENDATION
• Alphabet Inc (GOOGL). Cowen and Company raises target price to $1,725 from $1,525, as they are increasing Q2 2020 advertising estimates based on a recent check call.
• Delta Air Lines Inc (DAL). JPMorgan raises target price to $45 from $41, following commentary that was broadly consistent with expectations with regard to stalling demand growth and Q3 revenue and cost guidance. Current liquidity emerged slightly better than forecasted.
• JPMorgan Chase & Co (JPM). Evercore ISI raises target price to $110 from $108, after the company’s second-quarter earnings beat estimates.
• Moderna Inc (MRNA). Piper Sandler raises target price to $134 from $100, by increasing value for SARS-CoV-2 vaccine mRNA-1273 following positive Phase I data and ahead of Phase III trial start later this month. They also see projected enterprise value of $49.92 billion, up from $36.79 billion.
• Wells Fargo & Co (WFC). RBC cuts target price to $25 from $29, saying the combination of a "vice-like" grip on revenues due to the asset cap limit and a lower net interest margin combined with elevated credit costs has the bank in a very difficult position.


ECONOMIC EVENTS (All timings in U.S. Eastern Time)
0830 NY Fed Manufacturing for Jul: Expected 10.0; Prior -0.20
0830 Import prices mm for Jun: Expected 1.0%; Prior 1.0%
0830 Export prices mm for Jun: Expected 0.8%; Prior 0.5%
0830 Import prices yy for Jun: Prior -6.0%
0915 Industrial production mm for Jun: Expected 4.3%; Prior 1.4%
0915 Capacity utilization SA for Jun: Expected 67.7%; Prior 64.8%
0915 Manufacturing output mm for Jun: Expected 5.6%; Prior 3.8%
0915 Industrial production YoY for Jun: Prior -15.27%


COMPANIES REPORTING RESULTS
No major S&P 500 companies scheduled to report.


CORPORATE EVENTS (All timings in U.S. Eastern Time)
0800 Bank of New York Mellon Corp (BK). Q2 earnings conference call
0800 Credit Acceptance Corp (CACC). Annual Shareholders Meeting
0845 UnitedHealth Group Inc (UNH). Q2 earnings conference call
0900 U.S. Bancorp (USB). Q2 earnings conference call
0930 Goldman Sachs Group Inc (GS). Q2 earnings conference call
0930 PNC Financial Services Group Inc (PNC). Q2 earnings conference call
1130 VMware Inc (VMW). Annual Shareholders Meeting


EX-DIVIDENDS
Owens Corning (OC). Amount $0.24
RPM International Inc (RPM). Amount $0.36
Watsco Inc (WSO). Amount $1.77
Watsco Inc (WSOb). Amount $1.77

Goedemorgen
Nabeurs nieuws van het bedrijf Moderna waar wordt gemeld dat het experimenterend vaccin voldoende antilichamen produceert tegen COVID-19 bij alle 45 test personen, het aandeel schoot na het nieuws meteen 16% omhoog en we zien dat de futures die al op het hoogste punt van de sessie afsloten gisteren vanmorgen opnieuw 1% hoger staan. Opvallend blijft dat de Nasdaq opnieuw niet kan volgen zo te zien, de draai lijkt te zorgen voor een grote sector rotatie, van de ene bubbel naar de andere dan maar? Het gaat om een 1e testfase, het is niet zo dat er morgen al een vaccin klaar ligt, maar de markt blijft fors reageren op nieuw rondom een vaccin uiteraard, het brengt hoop maar ik zie nog steeds dat we in slecht weer zitten wat betreft de economie.

Dat is natuurlijk het nieuws van de dag, nu maar weer eens zien hoe de markten zullen verlopen de rest van de dag want het lijkt erop dat de Dow Jones nu het voortouw neemt, gisteren waren het vooral de cyclische waarden die goed voor de dag kwamen. Denk hierbij aan Caterpillar maar ook de oliereuzen deden het goed met stevige plussen voor Exxon en Chevron. Wel sluiten alle 30 de Dow aandelen in de plus gisteren. Zoals ik al aangaf bleef de Nasdaq achter deze keer, de index kwam wel heel sterk terug vanaf de laagste stand van de sessie waar er op een gegeven moment een verlies van 250 punten op de borden stond. Bij de Nasdaq 100 was dat zelfs 300 punten op een gegeven moment. Men na fors wint bij de tech maar de diepe dip werd wel snel opgekocht. Het is nog steeds zo dat de Tech aandelen te duur zijn momenteel, blijf daar de komende periode rekening mee houden.

De cijfers van ASML die net binnen zijn vallen op zich mee maar er zijn wat twijfels over het aantal nieuwe orders wat flink minder is dan wat er op de plank lag na het eerste kwartaal. De koers van ASML maakte gisteren al een duik, nu is het afwachten hoe het aandeel zal reageren op de cijfers straks.

Zo gek is de markt op dit moment!!
Dan nog iets wat perfect past in deze markt, het aandeel Tiziana Live Sciences met op de beurs ticker code TLSA verdrievoudigde zijn beurswaarde (+300%) de afgelopen periode door dat de code lijkt op die van Tesla (TSLA). Zo zie je maar weer hoeveel onbenullen er momenteel bezig zijn met de beurs momenteel. Let wel, ik wil niemand beledigen alleen wil ik hiermee aangeven dat je op de beurs zeer goed moet voorbereid moet zijn voor je eraan begint.

Goed, gisteren winst genomen op de Nasdaq positie en eerder al wat afgebouwd om in de loop van de dag uit te kunnen kijken naar wat nieuwe posities. Er lopen nu nog wat kleine posities maar ook daar met kansen, het gaat om 2 indexen nog. De kans is groot dat er weer eentje bij komt vandaag. Wie mee wil kan lid worden via de aanbieding die loopt tot 1 september ... Dan krijgt u de suggesties en signalen, kunt u de updates inzien en krijgt u toegang tot de Tradershop ...

Schrijf u in via de link https://www.usmarkets.nl/tradershop

Tot straks ... Guy

GLOBAL TOP NEWS
President Donald Trump on Tuesday ordered an end to Hong Kong's special status under U.S. law to punish China for what he called "oppressive actions" against the former British colony, prompting Beijing to warn of retaliatory sanctions.

The Bank of Japan kept monetary policy steady and maintained its view that the economy would gradually emerge from the coronavirus pandemic's devastating blow, signalling a pause after delivering stimulus twice so far this year.

Moderna's experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, U.S. researchers reported on Tuesday.


EUROPEAN COMPANY NEWS
Prime Minister Boris Johnson ordered Huawei equipment to be purged completely from Britain's 5G network by the end of 2027, risking the ire of China by signalling that the world's biggest telecoms equipment maker is not welcome in the West.

Apple's clash with EU competition regulators comes to a head on Wednesday as Europe's second-highest court rules on whether it has to pay 13 billion euros in Irish back taxes, a key part of the EU's crackdown against sweetheart tax deals.

The Italian government has given a mandate to the Economy and Transport ministers to reach a final agreement with the infrastructure group Atlantia, controlled by the Benetton family, to settle a long-running dispute over a motorway concession, a source said on Wednesday.


TODAY'S COMPANY ANNOUNCEMENTS
Duni AB Q2 2020 Earnings Call
Elanders AB HY 2020 Earnings Call
Elisa Oyj Q2 2020 Earnings Call
Fritz Nols AG Annual Shareholders Meeting
HMS Networks AB Q2 2020 Earnings Call
InTiCa Systems AG Annual Shareholders Meeting
Inwido AB (publ) Q2 2020 Earnings Call
Jpmorgan European Investment Trust PLC Annual Shareholders Meeting
Kongsberg Gruppen ASA Q2 2020 Earnings Presentation
Marlowe PLC Shareholders Meeting
McCarthy & Stone PLC HY 2020 Earnings Call
mwb Fairtrade Wertpapierhandelsbank AG Annual Shareholders Meeting
Nattopharma ASA Q2 2020 Earnings Call
Nova Re Siiq SPA Annual Shareholders Meeting
Octopus AIM VCT PLC Annual Shareholders Meeting
Omega Diagnostics Group PLC FY 2020 Earnings Call
Pandox AB Q2 2020 Earnings Call
Petro Welt Technologies AG Annual Shareholders Meeting
Proact IT Group AB Q2 2020 Earnings Call
Qliro Group AB (publ) Q2 2020 Earnings Call
Realtech AG Annual Shareholders Meeting
Sapmer SA Annual Shareholders Meeting
Sbanken ASA Q2 2020 Earnings Call
Semcon AB Q2 2020 Earnings Release
Severn Trent PLC Annual Shareholders Meeting
Skandinaviska Enskilda Banken AB Q2 2020 Earnings Call
Storebrand ASA Q2 2020 Earnings Call
Svenska Handelsbanken AB Q2 2020 Earnings Call
Tele2 AB Q2 2020 Earnings Call
Temenos AG Q2 2020 Earnings Call
TomTom NV Q2 2020 Earnings Call
Tullow Oil PLC Shareholders Meeting
Zaim Credit Systems PLC Annual Shareholders Meeting


ECONOMIC EVENTS (All times GMT)
0600 United Kingdom Core CPI mm for Jun: Expected -0.1%; Prior 0.0%
0600 United Kingdom Core CPI yy for Jun: Expected 1.2%; Prior 1.2%
0600 United Kingdom CPI mm for Jun: Expected 0.0%; Prior 0.0%
0600 United Kingdom CPI yy for Jun: Expected 0.4%; Prior 0.5%
0600 United Kingdom RPI mm for Jun: Expected 0.2%; Prior -0.1%
0600 United Kingdom RPI yy for Jun: Expected 1.0%; Prior 1.0%
0600 United Kingdom RPI-X (Retail Prices) mm for Jun: Prior 0.0%
0600 United Kingdom RPIX yy for Jun: Prior 1.3%
0600 (approx.) United Kingdom RPI Index for Jun: Prior 292.2
0600 (approx.) United Kingdom CPI NSA for Jun: Prior 108.5
0600 United Kingdom PPI Input Prices mm NSA for Jun: Expected 3.0%; Prior 0.3%
0600 United Kingdom PPI Input Prices yy NSA for Jun: Expected -6.5%; Prior -10.0%
0600 United Kingdom PPI Output Prices mm NSA for Jun: Expected 0.2%; Prior -0.3%
0600 United Kingdom PPI Output Prices yy NSA for Jun: Expected -1.1%; Prior -1.4%
0600 United Kingdom PPI Core Output mm NSA for Jun: Expected 0.0%; Prior 0.0%
0600 United Kingdom PPI Core Output yy NSA for Jun: Expected 0.6%; Prior 0.6%
0600 (approx.) Sweden Money Mkt CPIF Inflation 1 Yr for Jul: Prior 0.8%
0600 (approx.) Sweden Money Mkt CPIF Inflation 5 Yrs for Jul: Prior 1.7%
0800 (approx.) Italy CPI Excl Tobacco for Jun: Expected ; Prior 102.3
0800 (approx.) Italy CPI Excl Tobacco M/M for Jun: Prior -0.4%
0800 (approx.) Italy Consumer Prices Final mm for Jun: Expected 0.1%; Prior 0.1%
0800 (approx.) Italy Consumer Prices Final yy for Jun: Expected -0.2%; Prior -0.2%
0800 (approx.) Italy CPI (EU Norm) Final mm for Jun: Expected 0.0%; Prior 0.0%
0800 (approx.) Italy CPI (EU Norm) Final yy for Jun: Expected -0.4%; Prior -0.4%
1000 (approx.) Euro Zone Reserve Assets Total for Jun: Prior 895.81 bln EUR